PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 33992966-6 2021 This electrode showed selectivity for PSA in the presence of bovine serum albumin, glucose and L-cysteine. Cysteine 95-105 kallikrein related peptidase 3 Homo sapiens 38-41 24900791-1 2014 Peptide "B-2", which is one of the most potent kallikrein-related peptidase 3 (KLK3)-stimulating compounds, consists of 12 amino acids and is cyclized by a disulfide bridge between the N- and C-terminal cysteines. Cysteine 203-212 kallikrein related peptidase 3 Homo sapiens 79-83 27049934-4 2016 An efficient SERS nanoprobe has been constructed using gold nanoparticles as SERS substrate, and the TPE-In as the Raman reporter, which conjugated with a specific peptide substrate, Cys-Ser-Lys-Leu-Gln-OH, well-known for the recognition of prostate-specific antigen (PSA). Cysteine 183-186 kallikrein related peptidase 3 Homo sapiens 241-272 33225684-3 2020 The PSA peptides, without free carboxyl sites, are attached to the gold surface via the N-terminal cysteine residue. Cysteine 99-107 kallikrein related peptidase 3 Homo sapiens 4-7 30775253-7 2019 This unique, and essentially universal, secretion of enzymatically active PSA into the ECF by mCRPCs creates an exploitable therapeutic index for activation of systemically delivered highly lipophilic toxins as "molecular grenades" covalently linked to cysteine-34 of human serum albumin (HSA) via a stable maleimide containing PSA cleavable peptide such that PSA-dependent hydrolysis (i.e., "detonation") releases the grenades restrictively within the ECF of mCRPC. Cysteine 253-261 kallikrein related peptidase 3 Homo sapiens 74-77 19159616-7 2009 This indicated that it is the accessabilty of the Cys 191-Cys 220 disulfide near the catalytic serine 195 that decides on the ability of reductants to inactivate the proteolytic activity of PSA. Cysteine 50-53 kallikrein related peptidase 3 Homo sapiens 190-193 21853037-10 2011 The inclusion of serum cysteine to a model with PSA and biopsy Gleason grade improved prediction over the clinical variables alone (p<0.001). Cysteine 23-31 kallikrein related peptidase 3 Homo sapiens 48-51 19967419-0 2010 Mimetics of the disulfide bridge between the N- and C-terminal cysteines of the KLK3-stimulating peptide B-2. Cysteine 63-72 kallikrein related peptidase 3 Homo sapiens 80-84 19159616-7 2009 This indicated that it is the accessabilty of the Cys 191-Cys 220 disulfide near the catalytic serine 195 that decides on the ability of reductants to inactivate the proteolytic activity of PSA. Cysteine 58-61 kallikrein related peptidase 3 Homo sapiens 190-193 3691800-4 1987 gamma-Sm also hydrolyzed the -Phe/Glu- of lysozyme and the -Leu/Cys(SO3H)- of insulin B chain. Cysteine 64-67 kallikrein related peptidase 3 Homo sapiens 0-8 11747453-8 2001 Cys(344), which corresponds to Met(358), the P(1) site of alpha1-antitrypsin, was the inhibitory site for elastase-like proteases and PSA, while the preceding residue, Phe(343), was the inhibitory site for chymotrypsin-like proteases. Cysteine 0-3 kallikrein related peptidase 3 Homo sapiens 134-137 11067810-9 2000 CONCLUSIONS: With site-specific (cysteine tail) covalent attachment of Fab fragments on a microparticle, subattomole amounts of PSA can be detected quantitatively. Cysteine 33-41 kallikrein related peptidase 3 Homo sapiens 128-131 11012675-8 2000 A peptide with four cysteines showed the highest affinity for PSA. Cysteine 20-29 kallikrein related peptidase 3 Homo sapiens 62-65